Mangoceuticals (MGRX) EV to EBITDA (2023 - 2026)
Mangoceuticals' (MGRX) quarterly EV to EBITDA came in at 6.39 in Q2 2026, down 109.55% year-over-year from 66.91 in Q2 2025, and down 237.51% quarter-over-quarter from 1.89 in Q1 2026.
Powered by 
Analysis
Mangoceuticals (MGRX) EV to EBITDA (2023 - 2026) Analysis & Trends
Mangoceuticals has disclosed EV to EBITDA across 4 years of filings, most recently posting 6.39 for Q2 2026.
- In Q2 2026, EV to EBITDA fell 109.55% year-over-year to 6.39; the TTM figure through Jun 2026 stood at 0.55 (up 54.79% YoY), while the FY2025 annual figure was 0.33, up 44.36% from the prior year.
- EV to EBITDA came in at 6.39 for Q2 2026 at Mangoceuticals, down from 1.89 in the prior quarter.
- In the past five years, EV to EBITDA ranged from a high of 1.44 in Q4 2023 to a low of 16.13 in Q4 2025.
- Average EV to EBITDA over 4 years is 5.0, with a median of 3.41 recorded in 2025.
- Year-over-year, EV to EBITDA soared 68.0% in 2024 and tumbled 474.2% in 2025.
- Over 4 years, EV to EBITDA stood at 1.44 in 2023, then slumped by 94.67% to 2.81 in 2024, then plunged by 474.2% to 16.13 in 2025, then surged by 60.4% to 6.39 in 2026.
- Per Business Quant data, the three most recent EV to EBITDA figures were 6.39 in Q2 2026, 1.89 in Q1 2026, and 16.13 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Hinge Health | 7.41 Bn | 7.03 Bn | 183.95 Mn |
| 2 | Hims & Hers Health | 6.47 Bn | 5.63 Bn | 480.80 Mn |
| 3 | Ethos Technologies | 2.54 Bn | 2.37 Bn | 185.54 Mn |
| 4 | Omada Health | 1.38 Bn | 1.16 Bn | 63.79 Mn |
| 5 | Teladoc Health | 1.14 Bn | 366.41 Mn | 416.09 Mn |
| 6 | Talkspace | 870.58 Mn | 779.48 Mn | 24.80 Mn |
| 7 | Akso Health | 259.44 Mn | 259.25 Mn | - |
| 8 | LifeMD | 147.29 Mn | 147.29 Mn | - |
| 9 | eHealth | 31.71 Mn | -69.34 Mn | - |
| 10 | Mangoceuticals | 7.39 Mn | 7.14 Mn | 44,215.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.39 |
| Mar 31, 2026 | -1.89 |
| Dec 31, 2025 | -16.13 |
| Sep 30, 2025 | -3.28 |
| Jun 30, 2025 | -3.05 |
| Mar 31, 2025 | -1.94 |
| Dec 31, 2024 | -2.81 |
| Sep 30, 2024 | -4.25 |
| Jun 30, 2024 | -3.86 |
| Mar 31, 2024 | -2.16 |
| Dec 31, 2023 | -1.44 |
| Sep 30, 2023 | -7.25 |
| Jun 30, 2023 | -12.06 |
| Mar 31, 2023 | -3.53 |